APA (7th ed.) Citation

Campbell, P. M., Cantarovich, M., Gangji, A., Houde, I., Jevnikar, A. M., Monroy‐Cuadros, F., . . . Rush, D. N. (2024). A Five‐Year Prospective, Randomized, Open‐Label Study of Standard‐Dose Versus Low‐Dose Prolonged‐Release Tacrolimus With or Without Angiotensin‐Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation. Wiley. https://doi.org/10.1111/ctr.70067

Chicago Style (17th ed.) Citation

Campbell, Patricia M., et al. A Five‐Year Prospective, Randomized, Open‐Label Study of Standard‐Dose Versus Low‐Dose Prolonged‐Release Tacrolimus With or Without Angiotensin‐Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation. Wiley, 2024. https://doi.org/10.1111/ctr.70067.

MLA (9th ed.) Citation

Campbell, Patricia M., et al. A Five‐Year Prospective, Randomized, Open‐Label Study of Standard‐Dose Versus Low‐Dose Prolonged‐Release Tacrolimus With or Without Angiotensin‐Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation. Wiley, 2024. https://doi.org/10.1111/ctr.70067.